Longitudinal Partial Volume Correction in 2-[18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Studies of Alzheimer Disease

被引:2
作者
Malpas, Charles B. [1 ,2 ]
Saling, Michael M. [2 ,3 ,4 ]
Velakoulis, Dennis [1 ,5 ,6 ]
Desmond, Patricia [1 ,7 ,8 ]
Hicks, Rodney J. [7 ,10 ]
O'Brien, Terence J. [1 ,9 ]
机构
[1] Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia
[3] Austin Hlth, Dept Neuropsychol, Austin, Australia
[4] Austin Hosp, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin, Australia
[5] Royal Melbourne Hosp, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Psychiat, Melbourne, Vic 3010, Australia
[7] Univ Melbourne, Dept Radiol, Melbourne, Vic 3010, Australia
[8] Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia
[9] Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia
[10] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
NEUROIMAGING INITIATIVE ADNI; FDG-PET; F-18-FDG PET; ROBUST; ACCURATE; OPTIMIZATION; REGISTRATION; PERFORMANCE; DIAGNOSIS; DEMENTIA;
D O I
10.1097/RCT.0000000000000256
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective To investigate partial volume correction (PVC) of 2-[F-18]-fluoro-2-deoxy-d-glucose positron emission tomography in Alzheimer disease in a longitudinal context. Methods A total of 115 participants were included, including 55 controls, 53 patients with mild cognitive impairment, and 7 patients with dementia of the Alzheimer type. Imaging was performed at baseline and 24 months. Partial volume corrected vs uncorrected rates of longitudinal change were compared for mesial temporal and cortical regions of interest. Results Partial volume correction increased apparent uptake, and this effect was greater at 24 months compared with baseline. Partial volume correction decreased the rate of decline, causing an apparent increase in uptake at 24 months compared with baseline. This effect was correlated with the structural atrophy. Conclusions These findings suggest that applying PVC in a longitudinal context in Alzheimer disease might produce unpredictable results. Accordingly, both PVC corrected and uncorrected data should be reported to ensure that the results are physiologically plausible.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 31 条
[1]   Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease [J].
Arlt, Soenke ;
Brassen, Stefanie ;
Jahn, Holger ;
Wilke, Florian ;
Eichenlaub, Martin ;
Apostolova, Ivayla ;
Wenzel, Fabian ;
Thiele, Frank ;
Young, Stewart ;
Buchert, Ralph .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (07) :1090-1100
[2]   Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature [J].
Bohnen, Nicolaas I. ;
Djang, David S. W. ;
Herholz, Karl ;
Anzai, Yoshimi ;
Minoshima, Satoshi .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (01) :59-71
[3]   Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer's disease using automated image analysis [J].
Chen, Wei-Ping ;
Samuraki, Miharu ;
Yanase, Daisuke ;
Shima, Keisuke ;
Takeda, Nozomi ;
Ono, Kenjiro ;
Yoshita, Mitsuhiro ;
Nishimura, Shintaro ;
Yamada, Masahitio ;
Matsunari, Ichiro .
NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (03) :270-276
[4]  
Foster NLN, 2008, ALZHEIMERS DEMENT S1, V4
[5]   FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease [J].
Foster, Norman L. ;
Heidebrink, Judith L. ;
Clark, Christopher M. ;
Jagust, William J. ;
Arnold, Steven E. ;
Barbas, Nancy R. ;
DeCarli, Charles S. ;
Turner, R. Scott ;
Koeppe, Robert A. ;
Higdon, Roger ;
Minoshima, Satoshi .
BRAIN, 2007, 130 :2616-2635
[6]   Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects [J].
Hodges, John R. .
BRAIN, 2006, 129 :2811-2822
[7]   The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods [J].
Jack, Clifford R., Jr. ;
Bernstein, Matt A. ;
Fox, Nick C. ;
Thompson, Paul ;
Alexander, Gene ;
Harvey, Danielle ;
Borowski, Bret ;
Britson, Paula J. ;
Whitwell, Jennifer L. ;
Ward, Chadwick ;
Dale, Anders M. ;
Felmlee, Joel P. ;
Gunter, Jeffrey L. ;
Hill, Derek L. G. ;
Killiany, Ron ;
Schuff, Norbert ;
Fox-Bosetti, Sabrina ;
Lin, Chen ;
Studholme, Colin ;
DeCarli, Charles S. ;
Krueger, Gunnar ;
Ward, Heidi A. ;
Metzger, Gregory J. ;
Scott, Katherine T. ;
Mallozzi, Richard ;
Blezek, Daniel ;
Levy, Joshua ;
Debbins, Josef P. ;
Fleisher, Adam S. ;
Albert, Marilyn ;
Green, Robert ;
Bartzokis, George ;
Glover, Gary ;
Mugler, John ;
Weiner, Michael W. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 27 (04) :685-691
[8]   What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? [J].
Jagust, W. ;
Reed, B. ;
Mungas, D. ;
Ellis, W. ;
DeCarli, C. .
NEUROLOGY, 2007, 69 (09) :871-877
[9]   The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core [J].
Jagust, William J. ;
Bandy, Dan ;
Chen, Kewei ;
Foster, Norman L. ;
Landau, Susan M. ;
Mathis, Chester A. ;
Price, Julie C. ;
Reiman, Eric M. ;
Skovronsky, Daniel ;
Koeppe, Robert A. .
ALZHEIMERS & DEMENTIA, 2010, 6 (03) :221-229
[10]   Improved optimization for the robust and accurate linear registration and motion correction of brain images [J].
Jenkinson, M ;
Bannister, P ;
Brady, M ;
Smith, S .
NEUROIMAGE, 2002, 17 (02) :825-841